6-Bromo-4-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile, 98%, 25g

1-(3-Fluorophenyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 250mg

(E)-4-(3-Chloro-phenyl)-but-3-en-2-one, 95.0%, 5g

5-(Benzyloxy)-2-bromoaniline, 98+%, 250mg

Acétate d'isopropényle, min.98%, pour la synthèse, 250 ml, emballage en verre

Potassium Trifluoro(2-phenylethyl)borate>98.0%(HPLC)1g

4-(Dimethylamino)benzenesulfonic acid, 97.0%, 250mg

(2E)-1-(2,4-dimethoxyphenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

1-(3-chlorophenyl)-3-ethyl-4,5-dihydro-1H-pyrazol-5-one, 95.0%, 2g

6-Chlorobenzo[d]isoxazole, 97%, 1g

4-Amino-2-bromopyrimidine, 95.0%, 5g

tert-Butyl 4-(pyrrolidin-3-yl)piperazine-1-carboxylate hydrochloride, 97%, 2.5g

Tulobuterol Hydrochloride>98.0%(HPLC)(T)100mg